According to the author, BioInformant, this soon to be released 2013 edition of “Capitalizing on Opportunities in Cord Blood Industry Growth” details the cord blood banking industry’s 2,100% growth in the past and its growth potential.
Immunetics, Inc. announced plans to present a novel, rapid test for bacterial contamination of platelets at the American Association of Blood Banks (AABB) Annual Meeting, Oct. 21st-25th, in San Diego
Immunetics Receives $500,000 from Massachusetts Life Sciences Center to Commercialize BacTx® Test for Bacterial Contamination in Platelet Transfusions
Immunetics was awarded a $2.4 million, 3-year Phase II SBIR grant by the National Institutes of Health (NIH) to support clinical trials of the company's new confirmatory test for Chagas’ disease, a serious & potentially fatal parasitic infection.
By Veriteq Instruments
FDA 483 letters are expected to increase this year, reflecting the FDA’s recent staff expansion and rewrite of the FDA 483 Letter rules to narrow response time to the new 15-day window.